Table of Content


List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Yellow Fever - Overview
Yellow Fever - Therapeutics Development
Pipeline Overview
Pipeline by Companies
Pipeline by Universities/Institutes
Products under Development by Companies
Products under Development by Universities/Institutes
Yellow Fever - Therapeutics Assessment
Assessment by Target
Assessment by Mechanism of Action
Assessment by Route of Administration
Assessment by Molecule Type
Yellow Fever - Companies Involved in Therapeutics Development
Bavarian Nordic A/S
BioCryst Pharmaceuticals Inc
Curevac AG
Emergex Vaccines Holding Ltd
Enid Therapeutics LLC
Fab’entech SA
iBio Inc
Imutex Ltd
Medigen Inc
jit Technologies Inc
Orgenesis Inc
Sanofi
Serum Institute of India Ltd
Smart Biotech LLC
Tychan Pte Ltd
Yellow Fever - Drug Profiles
AGS-v PLUS - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
EMX-001 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
FDX-000 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
galidesivir - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Hydrovax-YFV - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
SinSaVak - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules to Inhibit NS5 for Japanese Encephalitis and Viral Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Synthetic Peptides for Yellow Fever - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
TY-014 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Vaccines for Viral Infections - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
yellow fever vaccine - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
yellow fever vaccine 1 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Yellow Fever - Dormant Projects
Yellow Fever - Product Development Milestones
Featured News & Press Releases
Aug 19, 2020: Emergex and Bio-Manguinhos/Fiocruz elucidate T cell epitopes produced by commercial yellow fever vaccine
Jul 30, 2020: SMART Researchers develop potential antibody treatment for yellow fever in seven months
Jul 29, 2020: NEJM study demonstrates safety and efficacy of first novel monoclol antibody specifically developed to treat yellow fever
Nov 18, 2019: WuXi Biologics congratulates Tychan on the world’s first yellow fever antibody tested safe and efficacious in human volunteers
May 09, 2019: BioCryst completes Phase 1 clinical trial of galidesivir
Jan 02, 2019: BioCryst initiates phase 1 clinical trial of Galidesivir
Dec 13, 2018: WuXi Biologics congratulates Tychan on first-in-class monoclol antibody for Yellow fever after record 7 months of development
Dec 06, 2018: Tychan Begins Phase I Trials for First Ever Yellow Fever Drug
Sep 17, 2018: BioCryst receives additiol $3.5 million to fund clinical trials of Galidesivir in Yellow Fever
Jul 27, 2016: Bavarian Nordic Announces Initiation of NIH Sponsored Phase 1 Trial of MVA-BN-based Yellow Fever Vaccine
Jul 27, 2016: NIH launches early-stage yellow fever vaccine trial
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer



List of Figures


Number of Products under Development for Yellow Fever, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Number of Products by Targets, H2 2020
Number of Products by Stage and Targets, H2 2020
Number of Products by Mechanism of Actions, H2 2020
Number of Products by Stage and Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Yellow Fever, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Yellow Fever - Pipeline by Bavarian Nordic A/S, H2 2020
Yellow Fever - Pipeline by BioCryst Pharmaceuticals Inc, H2 2020
Yellow Fever - Pipeline by Curevac AG, H2 2020
Yellow Fever - Pipeline by Emergex Vaccines Holding Ltd, H2 2020
Yellow Fever - Pipeline by Ennaid Therapeutics LLC, H2 2020
Yellow Fever - Pipeline by Fab’entech SA, H2 2020
Yellow Fever - Pipeline by iBio Inc, H2 2020
Yellow Fever - Pipeline by Imutex Ltd, H2 2020
Yellow Fever - Pipeline by Medigen Inc, H2 2020
Yellow Fever - Pipeline by Najit Technologies Inc, H2 2020
Yellow Fever - Pipeline by Orgenesis Inc, H2 2020
Yellow Fever - Pipeline by Sanofi, H2 2020
Yellow Fever - Pipeline by Serum Institute of India Ltd, H2 2020
Yellow Fever - Pipeline by Smart Biotech LLC, H2 2020
Yellow Fever - Pipeline by Tychan Pte Ltd, H2 2020
Yellow Fever - Dormant Projects, H2 2020
Yellow Fever - Dormant Projects, H2 2020 (Contd..1), H2 2020